Apr 28, 2020
Philogen Announces Option Exercise by Janssen
Jan 07, 2020
Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration
Dec 30, 2019
Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.
Dec 07, 2019
Janssen to Acquire Investigational Bermekimab from XBiotech
May 14, 2019
Janssen Demonstrates Strong Commitment to Inflammatory Bowel Disease with Data from 25 Abstracts Presented at the 2019 Digestive Disease Week Annual Meeting
Apr 30, 2019
Psoriatic Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Mar 01, 2019
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI(TM)) for the Treatment of Moderate to Severe Plaque Psoriasis
Jan 25, 2019
Global Crohn's Disease Dynamic Market 2016-2018 & 2026: $13.8 Billion Market Will be Driven by Continued Strong Uptake of Johnson & Johnson's Interleukin 12/23 (IL-12/23) Inhibitor Stelara
Jan 23, 2019
Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation
Jan 11, 2019
Visiongain Report Offers Transformative Insights on $47bn Rheumatoid Arthritis Market
Nov 06, 2018
Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 06, 2018
Protagonist Therapeutics Announces Completion of Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200
Oct 26, 2018
Global Psoriasis Drugs Market to 2022: Increasing Preference for IL-inhibitor Therapy to Conventional TNF-inhibitors
Oct 11, 2018
Janssen To Highlight Data From Broad Rheumatology Portfolio At The 2018 Annual Meeting Of The American College Of Rheumatology
Oct 04, 2018
Prime Therapeutics inks value-based contract for Stelara® with Janssen
Oct 01, 2018
Digital Landscape: Ankylosing Spondylitis
Aug 03, 2018
Rheumatoid Arthritis Drugs Market to be Worth US$ 26,758.6 Mn by 2026, Says TMR
Jun 05, 2018
Celltrion Launches Bio CDMO Business for the Development of New Drugs
Apr 10, 2018
Pfizer's Xeljanz Barrels into Psoriatic Arthritis, Leaving Lilly's Recently Launched Taltz in its Wake, According to a Recently Published Study from Spherix Global Insights
Apr 06, 2018
Rheumatoid Arthritis Pricing, Reimbursement & Market Access 2018 - Visiongain Report